ArticleAnnals of neurology2026
Non-Synaptic Function and Localization of Syntaxin-Binding Protein 1 in a Mouse Model of STXBP1-Related Epileptic Encephalopathy.
Article in Annals of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveDe novo mutations in the syntaxin-binding protein 1 (STXBP1), encoded by STXBP1, are among the most prevalent causes of variable neurodevelopmental disorders, including epileptic encephalopathy, developmental delay, and movement disorders. Although STXBP1 has been proposed as a critical presynaptic protein controlling synaptic vesicle exocytosis, clinical phenotypes also suggest that its biological function could be more diverse.
methodsThe expression pattern of STXBP1 was studied using immunostaining in vitro and in vivo. Synaptosome isolation was performed to investigate the synaptic and non-synaptic localization of STXBP1 in the brain. STXBP1 immunoprecipitation followed by mass spectrometry (MS) was conducted to identify protein complexes interacting with STXBP1. Cre-in utero electroporation (IUE) was done on Stxbp1
resultsOur immunohistochemistry results demonstrated that STXBP1 expression in the cerebral cortex was developmentally regulated and was detected in neuronal soma and processes. STXBP1 was in both the synaptic and cytosolic fractions, interacting with neuronal cytoskeleton and membrane periodic structures. Interestingly, sparse Stxbp1 KO in the mouse forebrain led to cell-autonomous cell death, which was rescued by either wild-type STXBP1 or pathogenic mutants. However, Stxbp1 KO neurons rescued by pathogenic mutants exhibited impaired dendritic growth. Our results also showed that STXBP1 interacted with alpha II Spectrin and ARPC2 and is required for their localization on the neuronal membrane.
interpretationOur data suggest that STXBP1 has diverse functions in the nervous system and regulates the trafficking of membrane cytoskeleton proteins in the brain. ANN NEUROL 2025 ANN NEUROL 2026;99:796-808.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.